Organigram Global Inc. — Investor Relations & Filings
Filings indexed
648
across all filing types
Latest filing
2026-05-12
Regulatory Filings
Country
CA
Canada
Listing
TSX
OGI
Organigram Global Inc. is engaged in the production and sale of cannabis and cannabis-derived products. The company utilizes five state-of-the-art facilities, including one of the world's largest indoor cultivation sites, to produce high-quality, indoor-grown cannabis. Organigram develops and markets a portfolio of consumer brands targeting the adult recreational market, while also supplying condition-specific medical cannabis products. The organization prioritizes innovation, product development, and sustainability, aiming to redefine industry standards. Leveraging strategic international relationships, Organigram is actively expanding its global presence to broaden the worldwide reach of its high-quality products.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 52-109F2 - Certification of interim filings - CEO (E).pdf | 2026-05-12 | English | |
| Interim MD&A - English.pdf | 2026-05-12 | English | |
| Interim financial statements/report – English.pdf | 2026-05-12 | English | |
| News release - English.pdf | 2026-05-12 | English | |
| News release - English.pdf | 2026-05-06 | English | |
| Other material contracts - English.pdf | 2026-04-28 | English |
Browse filings by year
10 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 47646678 | 52-109F2 - Certification of interim filings - CEO (E).pdf | 2026-05-12 | English | ||
| 47646683 | Interim MD&A - English.pdf | 2026-05-12 | English | ||
| 47646723 | Interim financial statements/report – English.pdf | 2026-05-12 | English | ||
| 47646729 | News release - English.pdf | 2026-05-12 | English | ||
| 47646734 | News release - English.pdf | 2026-05-06 | English | ||
| 47646748 | Other material contracts - English.pdf | 2026-04-28 | English | ||
| 47646753 | Report of exempt distribution (45-106F1).pdf | 2026-04-27 | English | ||
| 34610160 | News release - English.pdf | 2026-04-15 | English | ||
| 34590428 | News release - English.pdf | 2026-04-15 | English | ||
| 33094773 | Report of voting results.pdf | 2026-03-31 | English | ||
| 33094791 | News release - English.pdf | 2026-03-31 | English | ||
| 33094775 | News release - English.pdf | 2026-03-31 | English | ||
| 33094779 | News release - English.pdf | 2026-03-31 | English | ||
| 47646757 | News release - English.pdf | 2026-03-23 | English | ||
| 47646799 | News release - English.pdf | 2026-03-10 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Organigram Global Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/46878/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=46878 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=46878 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=46878 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 46878}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Organigram Global Inc. (id: 46878)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.